Related Experiment Video

Updated: Jul 19, 2026

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct
07:10

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct

Published on: April 1, 2022

What's new in the management of acute pancreatitis?

A P Wilmer1

  • 1Division of Internal Medicine, Medical Intensive Care Unit, Gasthuisberg University Hospital, K.U. Leuven, Leuven, Belgium.

Current Opinion in Anaesthesiology
|October 4, 2006
PubMed

Insights

Acute severe pancreatitis has high mortality. Promising treatments like Lexipafant failed, but urinary trypsinogen activation peptide shows potential as a prognostic marker for pancreatitis severity.

Area of Science:

  • Gastroenterology and Hepatology
  • Critical Care Medicine
  • Surgical Research

Background:

  • Acute severe pancreatitis is a critical condition with significant mortality and complications.
  • Current management strategies are evolving with evidence-based analysis and guideline development.
  • Identifying early prognostic markers and effective treatments for systemic inflammation is crucial.

Purpose of the Study:

  • To review current knowledge and emerging research in acute severe pancreatitis.
  • To evaluate the efficacy of specific therapeutic agents and diagnostic markers.
  • To highlight advancements in managing complications like infected necrosis.

Main Methods:

  • Review of clinical trials and evidence-based analyses on acute pancreatitis.
  • Assessment of a platelet-activating factor antagonist (Lexipafant) in a large double-blind study.
  • Evaluation of urinary trypsinogen activation peptide as a prognostic marker.
  • Analysis of the role of anti-secretory therapy (octreotide) and radiological drainage techniques.

Main Results:

  • Lexipafant did not reduce organ failure or mortality in severe acute pancreatitis.
  • Urinary trypsinogen activation peptide is a potential candidate for early severity prediction.
  • Anti-secretory therapy with octreotide offers no benefit for acute pancreatitis patients.
  • Percutaneous, radiological drainage may be important for infected necrosis management.

Conclusions:

  • Despite setbacks with agents like Lexipafant, research continues to seek effective treatments for acute pancreatitis.
  • Urinary trypsinogen activation peptide shows promise as an early prognostic tool.
  • Current evidence does not support anti-secretory therapy, but interventional radiology offers new hope for complications.

More Related Videos

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection07:38

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection

Published on: May 10, 2024

Retroperitoneal Laparoscopic Debridement and Drainage for Pancreatic Abscess03:42

Retroperitoneal Laparoscopic Debridement and Drainage for Pancreatic Abscess

Published on: March 15, 2024

Related Concept Videos

Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Acute Pancreatitis I: Introduction01:25

Acute Pancreatitis I: Introduction

Acute pancreatitis is the sudden inflammation of the pancreas caused by the early activation of digestive enzymes, leading to the autodigestion of pancreatic tissue. This results in local inflammation and, in severe cases, systemic complications.EtiologyUnderstanding the underlying causes is crucial, as identifying the etiology guides treatment and anticipates complications. Acute pancreatitis can be triggered by various factors, typically grouped into the following clinical categories.Biliary...
Acute Pancreatitis I: Introduction01:27

Acute Pancreatitis I: Introduction

Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...